Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A flow-regulating device to control differential pressure in CSF shunt systems. Technical note

H Yamada

    Journal of Neurosurgery
    |October 1, 1982
    PubMed
    Summary

    A novel flow-regulating device (FRD) effectively reduces cerebrospinal fluid (CSF) shunt flow by 30%. This simple Teflon tube modification enhances existing shunt valves, proving reliable in 32 patients without causing obstruction.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Purification and characterization of glycerate kinase from a serine-producing methylotroph, Hyphomicrobium methylovorum GM2.

    European journal of biochemistry·1992
    Same author

    Costimulation of T cell receptor/CD3-mediated activation of resting human CD4+ T cells by leukocyte function-associated antigen-1 ligand intercellular cell adhesion molecule-1 involves prolonged inositol phospholipid hydrolysis and sustained increase of intracellular Ca2+ levels.

    Journal of immunology (Baltimore, Md. : 1950)·1992
    Same author

    Proliferative assessment of craniopharyngioma and epidermoid by nucleolar organizer region staining.

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·1992
    Same author

    [A case of cardiac sarcoidosis associated with various clinical symptoms and thrombocytopenia].

    Nihon Kyobu Shikkan Gakkai zasshi·1992
    Same author

    An adult case of severe chronic active Epstein-Barr virus infection syndrome.

    Internal medicine (Tokyo, Japan)·1992
    Same author

    Chemical and pharmacological studies on efficacy of Japanese and Chinese herbal medicines.

    The Kitasato archives of experimental medicine·1992

    Area of Science:

    • Neurosurgery
    • Biomedical Engineering
    • Medical Devices

    Background:

    • Cerebrospinal fluid (CSF) shunts are crucial for managing hydrocephalus.
    • Existing shunt systems may require recalibration or replacement to achieve optimal flow rates.
    • Modifications to shunt systems are needed to fine-tune CSF drainage without invasive procedures.

    Purpose of the Study:

    • To introduce and evaluate a novel flow-regulating device (FRD) for cerebrospinal fluid (CSF) shunts.
    • To assess the efficacy of the FRD in reducing CSF flow rate through standard shunts.
    • To determine the reliability and safety of the FRD in a clinical setting.

    Main Methods:

    • Development of a small-caliber (0.4 mm) Teflon tube as a flow-regulating device (FRD).
    • Placement of the FRD within the connector of existing CSF shunts.

    Related Experiment Videos

  • Experimental evaluation of the FRD's impact on CSF flow rate.
  • Clinical assessment of the FRD's reliability and safety in 32 patients.

    • Main Results:

    • The FRD successfully reduced the CSF flow rate by approximately 30% in experimental studies.
    • The device converted original shunt valves to higher-resistance flow valves.
    • The FRD was found to be reliable in 32 patients, with no instances of CSF obstruction.
    • The device demonstrated ease of installation and removal.

    Conclusions:

    • The novel FRD offers a simple and effective method for regulating CSF flow in shunts.
    • This modification enhances existing shunt systems, providing higher resistance without distal catheter replacement.
    • The FRD is a reliable, safe, and easily applicable solution for fine-tuning CSF drainage in patients.